Bone Biologics Corp (BBLG)’s stock has witnessed a price hike of 56.05% from the previous close with its current price standing at $3.23. Its current price is -80.42% under its 52-week high of $16.50 and 59.12% more than its 52-week low of $2.03. Based on the past 30-day period, the stock price is -7.38% below the high and +39.16% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, BBLG’s SMA-200 is $4.89.
BBLG’s price to book ratio for the most recent quarter was 0.83, resulting in an 0.87 price to cash per share for the period.
How does Bone Biologics Corp (BBLG) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 0 brokerage firms that recommend the stock as a Strong Sell. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 0.00 in simple terms.
Bone Biologics Corp (BBLG): Earnings History
Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 1 different analysts, who are expecting earnings to fall in between the range of -1.23 and -1.23 with an average Earnings Estimate of -1.23 which is in contrast with the last year earnings estimate of -14.22 and also replicates 91.35% growth rate year over year.
Bone Biologics Corp (NASDAQ: BBLG) Ownership Details
I will give a breakdown of the key shareholders in Bone Biologics Corp (BBLG). Recent figures show that the company’s insiders hold 8.31% of shares. A total of 5 institutional investors hold shares in the company, making 0.12% of its stock and 0.13% of its float.
Jun 30, 2025, it was reported that the Company’s largest institutional holder is Fidelity Concord Street Trust-Fidelity Extended Market Index Fund holding total of 2.75 shares that make 0.15% of the company’s total number of shares and are currently priced at 10052.0.
The securities firm Fidelity Concord Street Trust-Fidelity Total Market Index Fund holds 656.0 shares of BBLG, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.04%, and the holding percentage of shares is valued at 2394.0.
An overview of Bone Biologics Corp’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Bone Biologics Corp (BBLG) traded 2,094,316 shares per day, with a moving average of $2.26 and price change of +0.18. With the moving average of $2.79 and a price change of -2.73, about 1,443,924 shares changed hands on average over the past 50 days. Finally, BBLG’s 100-day average volume is 742,032 shares, alongside a moving average of $3.73 and a price change of -1.30.
